Related Experiment Video
Updated: Jun 16, 2026

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
Published on: January 27, 2018
Tardive cervical dystonia
José Fidel Baizabal-Carvallo1,2, Joseph Jankovic3
1Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, USA. baizabaljf@hotmail.com.
None:
Tardive cervical dystonia (CD) is a frequent presentation of tardive syndromes, but it has not been extensively studied. We aimed to assess the clinical features of tardive CD and compared them with other tardive phenomena and idiopathic CD. Among 72 consecutive patients with tardive syndromes, CD was identified in 27 (37.5%) cases. Patients with tardive CD were younger and had a more severe clinical presentation with higher AIMS scores (P < 0.001). They also had more frequently associated comorbid facial/trunk dystonia and akathisia (P < 0.005) compared with other patients with tardive phenomena. Furthermore, patients with tardive CD were younger than those with idiopathic CD and had more phasic CD, retrocollis (head extension), facial/trunk dystonia, oro-bucco-lingual dyskinesia, limb chorea/stereotypies, akathisia, and parkinsonism (P < 0.005). No differences were observed in the severity of head deviation in any axis. Sustained CD, torticollis (head rotation), laterocollis (head tilt), alleviating maneuvers, restricted range of head motion, head tremor, and family history of CD were more common in patients with idiopathic CD compared to those with tardive CD (P ≤ 0.001). CD is observed in 37.5% of patients with tardive syndrome. In contrast to idiopathic CD, tardive CD tends to occur in younger individuals with phasic dystonia, retrocollis, and is typically associated with a variety of other hyperkinetic movement disorders.
More Related Videos
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Related Concept Videos
Alterations in Muscle Tone ll
Tetanus
Alterations in Muscle Tone lll
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Huntington Disease l: Introduction